BusinessAtlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD PouchitisBy Nasdaq OMXMay 2, 2018, 12:02 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:28 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
